News
AbbVie has entered into a $700 million licensing agreement with IGI Therapeutics to co-develop ISB 2001, a promising ...
A new report by the U.N. AIDS agency says the sudden withdrawal of U.S. funding has caused a “systemic shock” to the global effort against AIDS and HIV. Years of American-led investment into AIDS ...
US biopharma company AbbVie has inked a $700 million deal with IGI Therapeutics to develop and sell ISB 2001, an experimental drug for blood cancer.
Thousands of customers are set to receive payments after purchasing a weight loss supplement once described as the “Gastric ...
Other research, including a review of over 80 studies, found that AI chatbots are especially helpful for improving mood, reducing stress and even helping people sleep better. In one study, a chatbot ...
The global baby milk market is poised for substantial expansion, projected to grow from USD 17.2 billion in 2025 to USD 29.6 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results